Back
Staar Surgical Vs. Neurocrine Biosciences Industry Stock Comparison
Buy
70
STAA
Staar Surgical
Last Price:
45.48
Seasonality Move:
10.91%
Buy
53
NBIX
Neurocrine Biosciences
Last Price:
140.77
Seasonality Move:
8.72%
Buy
70
Staar Surgical (STAA)
is a Buy
Is Staar Surgical a Buy, Sell or Hold?
- The current Staar Surgical [STAA] share price is $45.51. The Score for STAA is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- STAA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $140.71. The Score for NBIX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
STAA Stock Price Chart
What is Staar Surgical's stock price today?
-
The Staar Surgical share price today is $45.51
The current trend is moderately bearish and STAA is experiencing selling pressure, which indicates risk of future bearish movement.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $140.71
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing slight buying pressure.
STAA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.15 | Buy |
| Relative Strength Index (14 RSI): | 52.22 | Buy |
| Chaikin Money Flow: | -206265 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.22 - 49.88) | Sell |
| Bollinger Bands (100): | (29.11 - 42.89) | Buy |
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.79 | Buy |
| Relative Strength Index (14 RSI): | 55.92 | Buy |
| Chaikin Money Flow: | 71950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (134.13 - 140.23) | Buy |
| Bollinger Bands (100): | (129.26 - 140.84) | Buy |
STAA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.33 | Sell |
| 20-day SMA: | 47.6 | Sell |
| 50-day SMA: | 41.23 | Buy |
| 200-day SMA: | 38.59 | Buy |
| 8-day EMA: | 46.06 | Sell |
| 20-day EMA: | 45.75 | Sell |
| 50-day EMA: | 42.2 | Buy |
| 200-day EMA: | 41.66 | Buy |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 139.09 | Buy |
| 20-day SMA: | 136.82 | Buy |
| 50-day SMA: | 137.3 | Buy |
| 200-day SMA: | 122.48 | Buy |
| 8-day EMA: | 139.15 | Buy |
| 20-day EMA: | 137.89 | Buy |
| 50-day EMA: | 136.76 | Buy |
| 200-day EMA: | 125.3 | Buy |
Staar Surgical Earnings Growth & STAA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.42 per share, and an increase next year of $0.39 per share.
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.03 per share, an increase this year of $1.78 per share, and an increase next year of $1.54 per share.
Staar Surgical Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurocrine Biosciences Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||